28 March, 2018

A cancer vaccine that uses an injectable scaffold loaded with a selection of tumor-expressed peptides proved more effective at stimulating anti-tumor responses and a tumor-specific immune memory in mouse models that kept the animals rejecting tumor cells at least half a year later.


No comments: